Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
13,516,993
-
Share change
-
-524,563
-
Total reported value
-
$113,943,965
-
Price per share
-
$8.43
-
Number of holders
-
30
-
Value change
-
-$7,929,067
-
Number of buys
-
17
-
Number of sells
-
23
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2014
As of 30 Jun 2014,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,516,993 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT CO LLP, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, WALL STREET ASSOCIATES, VANGUARD GROUP INC, MASON STREET ADVISORS, LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.